Clinical Trials Logo

Clinical Trial Summary

The assessment of severity of the cognitive and functional impairment is essential in the follow-up of patients with neurocognitive disorders and in the assessment of the effectiveness of therapeutics. However, the systematic assessment of the Clinical Dementia Rating (CDR) scale is limited due to the time required to complete it (approximately 45 min to 1 hour). Insofar as studies have shown correspondences between the CDR and scales measuring cognitive and neuropsychological performance, and as part of memory consultations, several functional and neuropsychological scales are systematically administered, we wish to conduct a study validating the feasibility of the CDR based on information already available in the patient's file compared to the evaluation of the CDR by the usual method (face-to-face interview in consultation). This study should highlight the feasibility of scoring the CDR-SB from the files of patients in memory consultation, first in terms of reliability of the scores obtained compared to the standard evaluation, and on the other hand in terms of organization and duration of administration.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Alzheimer Disease
  • Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient
  • Clinical Dementia Rating (CDR) From the Analysis of Medical Record
  • Dementia

NCT number NCT04763941
Study type Observational
Source Hospices Civils de Lyon
Contact Anthony Bathsavanis, Psy D
Phone 4 72 432 206
Email anthony.bathsavanis@chu-lyon.fr
Status Recruiting
Phase
Start date January 1, 2020
Completion date December 31, 2022